| High TUBB3 expression, an independent prognostic marker in patients with early non–small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling … G Levallet, E Bergot, M Antoine, C Creveuil, AO Santos, M Beau-Faller, ... Molecular cancer therapeutics 11 (5), 1203-1213, 2012 | 116 | 2012 |
| O6‐methylguanine‐DNA methyltransferase (MGMT) promoter methylation and low MGMT‐encoded protein expression as prognostic markers in glioblastoma … E Lechapt‐Zalcman, G Levallet, AE Dugue, A Vital, MD Diebold, P Menei, ... Cancer 118 (18), 4545-4554, 2012 | 109 | 2012 |
| RASSF1A suppresses the invasion and metastatic potential of human non–small cell lung cancer cells by inhibiting YAP activation through the GEF-H1/RhoB pathway F Dubois, M Keller, O Calvayrac, F Soncin, L Hoa, A Hergovich, ... Cancer research 76 (6), 1627-1640, 2016 | 105 | 2016 |
| [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis L Bekaert, S Valable, E Lechapt-Zalcman, K Ponte, S Collet, JM Constans, ... European Journal of Nuclear Medicine and Molecular Imaging 44, 1383-1392, 2017 | 91 | 2017 |
| An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial F de Fraipont, G Levallet, C Creveuil, E Bergot, M Beau-Faller, ... Clinical cancer research 18 (10), 2976-2986, 2012 | 63 | 2012 |
| RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis—An updated review F Dubois, E Bergot, G Zalcman, G Levallet Cell death & disease 10 (12), 928, 2019 | 61 | 2019 |
| Shorter survival in malignant pleural mesothelioma patients with high PD-L1 expression associated with sarcomatoid or biphasic histology subtype: a series of 214 cases from the … S Brosseau, C Danel, A Scherpereel, J Mazières, S Lantuejoul, J Margery, ... Clinical lung cancer 20 (5), e564-e575, 2019 | 58 | 2019 |
| Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group G Levallet, M Vaisse-Lesteven, N Le Stang, AGS Ilg, P Brochard, P Astoul, ... Journal of Thoracic Oncology 7 (3), 599-606, 2012 | 55 | 2012 |
| Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial V Quillien, A Lavenu, F Ducray, MO Joly, O Chinot, F Fina, M Sanson, ... Oncotarget 7 (38), 61916, 2016 | 52 | 2016 |
| Increased particulate phosphodiesterase 4 in the prefrontal cortex supports 5-HT4 receptor-induced improvement of object recognition memory in the rat G Levallet, M Hotte, M Boulouard, F Dauphin Psychopharmacology 202, 125-139, 2009 | 41 | 2009 |
| A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control F Dubois, B Jean-Jacques, H Roberge, M Bénard, L Galas, D Schapman, ... Cell Communication and Signaling 16, 1-20, 2018 | 36 | 2018 |
| Histopathologic diagnosis of brain metastases: current trends in management and future considerations L Bekaert, E Emery, G Levallet, E Lechapt-Zalcman Brain tumor pathology 34, 8-19, 2017 | 32 | 2017 |
| Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells G Levallet, J Levallet, H Bouraïma-Lelong, PJ Bonnamy Biology of reproduction 76 (5), 794-803, 2007 | 31 | 2007 |
| Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy E Bergot, G Levallet, K Campbell, F Dubois, E Lechapt, G Zalcman European Respiratory Review 22 (130), 565-576, 2013 | 30 | 2013 |
| Investigating tunneling nanotubes in cancer cells: Guidelines for structural and functional studies through cell imaging F Dubois, M Bénard, B Jean-Jacques, D Schapman, H Roberge, A Lebon, ... BioMed research international 2020 (1), 2701345, 2020 | 29 | 2020 |
| High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC: results from the IFCT PREDICT. amm study S Baldacci, M Figeac, M Antoine, C Descarpentries, Z Kherrouche, ... Journal of Thoracic Oncology 15 (1), 120-124, 2020 | 27 | 2020 |
| NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells M Keller, F Dubois, S Teulier, APJ Martin, J Levallet, E Maille, S Brosseau, ... Journal of Experimental & Clinical Cancer Research 38, 1-16, 2019 | 27 | 2019 |
| A biphasic and brain-region selective down-regulation of cyclic adenosine monophosphate concentrations supports object recognition in the rat M Hotte, F Dauphin, T Freret, M Boulouard, G Levallet PLoS One 7 (2), e32244, 2012 | 21 | 2012 |
| Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients V Quillien, A Lavenu, F Ducray, D Meyronet, O Chinot, F Fina, M Sanson, ... Cancer Biomarkers 20 (4), 435-441, 2017 | 19 | 2017 |
| Cancer and RASSF1A/RASSF1C, the two faces of Janus F Dubois, E Bergot, G Levallet Trends in Cancer 5 (11), 662-665, 2019 | 18 | 2019 |
